Evidence map›Paper›PMID 41136905›Full record

ArticleBMC medical research methodology2025

HILAMA: High-dimensional multi-omics mediation analysis with latent confounding.

Xinbo Wang, Junyuan Liu, Sheng'en Shawn Hu, Zhonghua Liu, Hui Lu, Lin Liu, and for the Alzheimer’s Disease Neuroimaging Initiative

Abstract read
In one paragraph

Article in BMC medical research methodology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Xinbo Wang *Department of Bioinformatics and Biostatistics, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, 200240, China. cinbo_w@sjtu.edu.cn.
Junyuan Liu *School of Mathematical Sciences, Shanghai Jiao Tong University, Shanghai, China.
Sheng'en Shawn HuDepartment of Genome Sciences, University of Virginia, Charlottesville, VA, USA.
Zhonghua LiuDepartment of Biostatistics, Columbia University, New York, NY, USA.
Hui LuDepartment of Bioinformatics and Biostatistics, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, 200240, China. huilu@sjtu.edu.cn.
Lin LiuSJTU-Yale Joint Center for Biostatistics and Data Science, Technical Center for Digital Medicine, National Center for Translational Medicine, Shanghai Jiao Tong University, Shanghai, 200240, China. linliu@sjtu.edu.cn.
and for the Alzheimer’s Disease Neuroimaging Initiative

Funding

National Science Foundations of China Grants No.12090024National Science Foundations of China Grants No. 12471274Science and Technology Commission of Shanghai Municipality No.23JS1400700
6 · The paper itself

Abstract

backgroundThe increasingly available multi-omics datasets have posed both new opportunities and challenges to the development of quantitative methods for discovering novel mechanisms in biomedical research. One natural approach to analyzing such datasets is mediation analysis originated from the causal inference literature. Mediation analysis can help unravel the mechanisms through which exposure(s) exert the effect on outcome(s). However, existing methods fail to consider the case where (1) both exposures and mediators are potentially high-dimensional and (2) it is very likely that some important confounding variables are unmeasured or latent; both issues are quite common in practice. To the best of our knowledge, however, no methods have been developed to address these challenges with statistical guarantees.

methodsIn this article, we propose a new method for HIgh-dimensional LAtent-confounding Mediation Analysis (HILAMA) that considers both high-dimensional exposures and mediators, as well as the possible existence of latent confounding variables. HILAMA employs the Decorrelating & Debiasing method to estimate the individual effects of exposures and mediators on the outcome. A column-wise regression strategy with parallel computing is considered to efficiently estimate the exposure-mediator effect matrix. HILAMA then applies the MinScreen procedure to eliminate non-significant pairs, and the Joint-Significance Testing (JST) method to compute p-values for the retained pairs, controlling the False Discovery Rate (FDR) using the Benjamini-Hochberg (BH) procedure.

resultsThe proposed method is evaluated through extensive simulation experiments, demonstrating its improved stability in FDR control and superior power in finite sample size compared to existing competitive methods. Furthermore, our method is applied to the proteomics-radiomics data from ADNI, identifying some key proteins and brain regions related to Alzheimer’s disease. These empirical results demonstrate that HILAMA can effectively control FDR and provide valid statistical inference for high dimensional mediation analysis with latent confounding variables under certain assumptions.

conclusionsHILAMA can effectively control FDR and provide valid statistical inference for high dimensional mediation analysis with latent confounding variables under certain assumptions.

Indexed as

Mediation AnalysisAlgorithmsAlzheimer DiseaseComputer SimulationConfounding Factors, EpidemiologicHumansModels, StatisticalMultiomicsAlzheimer’s diseaseFalse discovery rate controlHigh-dimensional mediation analysisLatent confoundingMulti-omics

Identifiers

PMID41136905
PMCPMC12551175

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.